576,266 Shares in Adaptive Biotechnologies Corporation $ADPT Bought by Wasatch Advisors LP
Market Beat·- Wasatch Advisors LP purchased a new position of 576,266 shares in Adaptive Biotechnologies Corporation valued at approximately $12,361,000 during the second quarter. - The biotechnology company reported quarterly revenue of $71.55 million with earnings per share of ($0.25), while maintaining a market capitalization of $4.03 billion. - Several institutional investors and insiders actively traded shares, alongside multiple brokerages issuing updated price targets and ratings for the stock.